846PD - Preliminary results from the TRITON2 study of rucaparib in patients (pts) with DNA damage repair (DDR)-deficient metastatic castration-resistant prostate cancer (mCRPC): Updated analyses
Abida, W., Campbell, D., Patnaik, A., Sautois, B., Shapiro, J., Vogelzang, N.J., Bryce, A.H., McDermott, R., Ricci, F., Rowe, J., Zhang, J., Simmons, A.D., Despain, D., Dowson, M., Golsorkhi, T., Chowdhury, S.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Preliminary results from the TRITON2 study of rucaparib in patients (pts) with DNA damage repair (DDR)-deficient metastatic castration-resistant prostate cancer (mCRPC): Updated analyses
Abida, W., Campbell, D., Patnaik, A., Sautois, B., Shapiro, J., Vogelzang, N.J., Bryce, A.H., McDermott, R., Ricci, F., Rowe, J., Zhang, J., Simmons, A.D., Despain, D., Dowson, M., Golsorkhi, T., Chowdhury, S.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
846PDPreliminary results from the TRITON2 study of rucaparib in patients (pts) with DNA damage repair (DDR)-deficient metastatic castration-resistant prostate cancer (mCRPC): Updated analyses
Abida, W, Campbell, D, Patnaik, A, Sautois, B, Shapiro, J, Vogelzang, N J, Bryce, A H, McDermott, R, Ricci, F, Rowe, J, Zhang, J, Simmons, A D, Despain, D, Dowson, M, Golsorkhi, T, Chowdhury, S
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
P2.03-058 Tiger-3: A Phase 3 Randomized Study of Rociletinib Vs Chemotherapy in EGFR-mutated Non-small Cell Lung Cancer (NSCLC)
Yang, J.C., Reckamp, K., Kim, Y., Novello, S., Smit, E., Lee, J., Su, W., Akerley, W., Blakely, C., Bazhenova, L., Chiari, R., Hsia, T., Golsorkhi, T., Despain, D., Shih, D., Rolfe, L., Popat, S., Wakelee, H.
Published in Journal of thoracic oncology (01.11.2017)
Published in Journal of thoracic oncology (01.11.2017)
Get full text
Journal Article
Genomic profiling of patients with metastatic castration-resistant prostate cancer (mCRPC) for the evaluation of rucaparib: Next-generation sequencing (NGS) of tumour tissue and cell-free DNA (cfDNA)
Piulats, J.M., Abida, W., McDermott, R., Shapiro, J.D., Ostler, P., Reaume, M.N., Mejlholm, I., Byard, I., Hussain, A., Morris, D., Campbell, D., Burke, J., Laguerre, B., Reid, A., Voog, E., Benjelloun, A., Spaeth, D., Goldfischer, E.R., Pintus, E., Loehr, A., Golsorkhi, T., Watkins, S.P., Ryan, C., Chowdhury, S.
Published in European urology supplements : official journal of the European Association of Urology (01.03.2019)
Published in European urology supplements : official journal of the European Association of Urology (01.03.2019)
Get full text
Journal Article
362 - Genomic profiling of patients with metastatic castration-resistant prostate cancer (mCRPC) for the evaluation of rucaparib: Next-generation sequencing (NGS) of tumour tissue and cell-free DNA (cfDNA)
Piulats, J.M., Abida, W., McDermott, R., Shapiro, J.D., Ostler, P., Reaume, M.N., Mejlholm, I., Byard, I., Hussain, A., Morris, D., Campbell, D., Burke, J., Laguerre, B., Reid, A., Voog, E., Benjelloun, A., Spaeth, D., Goldfischer, E.R., Pintus, E., Loehr, A., Golsorkhi, T., Watkins, S.P., Ryan, C., Chowdhury, S.
Published in European urology supplements : official journal of the European Association of Urology (01.03.2019)
Published in European urology supplements : official journal of the European Association of Urology (01.03.2019)
Get full text
Journal Article
P048 - The TRITON clinical trial programme: evaluation of the PARP inhibitor rucaparib in patients with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination deficiency (HRD)
Rodriguez-Vida, A., Arranz Arija, J.A., Daugaard, G., Fizazi, K., Gez, E., Heidenreich, A., Joly, F., Krieger, L., Mcdermott, R., Merseburger, A.S., Piulats, J.M., Sautois, B., Shapiro, J., Sridhar, S., Sternberg, C.N., Watkins, S., Simmons, A., Shetty, S., Golsorkhi, T., Abida, W., Ryan, C.J., Scher, H.I., Chowdhury, S.
Published in European urology supplements : official journal of the European Association of Urology (01.11.2017)
Published in European urology supplements : official journal of the European Association of Urology (01.11.2017)
Get full text
Journal Article
The TRITON clinical trial programme: evaluation of the PARP inhibitor rucaparib in patients with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination deficiency (HRD)
Rodriguez-Vida, A., Arranz Arija, J.A., Daugaard, G., Fizazi, K., Gez, E., Heidenreich, A., Joly, F., Krieger, L., Mcdermott, R., Merseburger, A.S., Piulats, J.M., Sautois, B., Shapiro, J., Sridhar, S., Sternberg, C.N., Watkins, S., Simmons, A., Shetty, S., Golsorkhi, T., Abida, W., Ryan, C.J., Scher, H.I., Chowdhury, S.
Published in European urology supplements : official journal of the European Association of Urology (01.11.2017)
Published in European urology supplements : official journal of the European Association of Urology (01.11.2017)
Get full text
Journal Article